Literature DB >> 25385336

Neuroimmunology: towards more-accurate diagnosis in neuromyelitis optica.

Kazuo Fujihara1, Jacqueline Palace2.   

Abstract

Neuromyelitis optica spectrum disorders (NMOSD) can mimic multiple sclerosis (MS). Avoiding misdiagnosis is crucial, because some disease-modifying drugs for MS can aggravate NMOSD, causing blindness and paraplegia. A recent study reports that misdiagnosis of NMOSD as MS occasionally occurs, and that a two-step antibody assay could improve differential diagnosis.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25385336     DOI： 10.1038/nrneurol.2014.216

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


  8 in total

1.  Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.

Authors:  P J Waters; A McKeon; M I Leite; S Rajasekharan; V A Lennon; A Villalobos; J Palace; J N Mandrekar; A Vincent; A Bar-Or; S J Pittock
Journal:  Neurology       Date:  2012-02-01       Impact factor: 9.910

2.  AQP4 antibody-positive Thai cases: clinical features and diagnostic problems.

Authors:  S Siritho; I Nakashima; T Takahashi; K Fujihara; N Prayoonwiwat
Journal:  Neurology       Date:  2011-08-03       Impact factor: 9.910

3.  Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity.

Authors:  Romain Marignier; Raphaël Bernard-Valnet; Pascale Giraudon; Nicolas Collongues; Caroline Papeix; Hélène Zéphir; Gaëlle Cavillon; Véronique Rogemond; Romain Casey; Bernard Frangoulis; Jérôme De Sèze; Sandra Vukusic; Jérôme Honnorat; Christian Confavreux
Journal:  Neurology       Date:  2013-05-08       Impact factor: 9.910

4.  Treatment of Neuromyelitis Optica: Review and Recommendations.

Authors:  Dorlan J Kimbrough; Kazuo Fujihara; Anu Jacob; Marco A Lana-Peixoto; Maria Isabel Leite; Michael Levy; Romain Marignier; Ichiro Nakashima; Jacqueline Palace; Jérôme de Seze; Olaf Stuve; Silvia N Tenembaum; Anthony Traboulsee; Emmanuelle Waubant; Brian G Weinshenker; Dean M Wingerchuk
Journal:  Mult Scler Relat Disord       Date:  2012-10       Impact factor: 4.339

5.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.

Authors:  Vanda A Lennon; Dean M Wingerchuk; Thomas J Kryzer; Sean J Pittock; Claudia F Lucchinetti; Kazuo Fujihara; Ichiro Nakashima; Brian G Weinshenker
Journal:  Lancet       Date:  2004 Dec 11-17       Impact factor: 79.321

6.  Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.

Authors:  Douglas Kazutoshi Sato; Ichiro Nakashima; Toshiyuki Takahashi; Tatsuro Misu; Patrick Waters; Hiroshi Kuroda; Shuhei Nishiyama; Chihiro Suzuki; Yoshiki Takai; Kazuo Fujihara; Yasuto Itoyama; Masashi Aoki
Journal:  Neurology       Date:  2013-05-15       Impact factor: 9.910

7.  Seroprevalence of aquaporin-4-IgG in a northern California population representative cohort of multiple sclerosis.

Authors:  Sean J Pittock; Vanda A Lennon; Nandini Bakshi; Ling Shen; Andrew McKeon; Hong Quach; Farren B S Briggs; Allan L Bernstein; Catherine A Schaefer; Lisa F Barcellos
Journal:  JAMA Neurol       Date:  2014-11       Impact factor: 18.302

8.  IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.

Authors:  Vanda A Lennon; Thomas J Kryzer; Sean J Pittock; A S Verkman; Shannon R Hinson
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307
  8 in total
  1 in total

Review 1.  Optical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.

Authors:  Praveena Manogaran; James V M Hanson; Elisabeth D Olbert; Christine Egger; Carla Wicki; Christina Gerth-Kahlert; Klara Landau; Sven Schippling
Journal:  Int J Mol Sci       Date:  2016-11-15       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.